Drug profile · INN
hetacillin potassium
VERSAPEN-K
hetacillin potassium (VERSAPEN-K) is a penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — hetacillin potassium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
hetacillin potassium (VERSAPEN-K) is a penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Penicillin-binding protein inhibitor
Primary target: Penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is hetacillin potassium?
hetacillin potassium (VERSAPEN-K) is a penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for hetacillin potassium?
VERSAPEN-K is a marketed brand name for hetacillin potassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hetacillin potassium?
hetacillin potassium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.